C₆₀ adduct with L-arginine as a promising nanomaterial for treating cerebral ischemic stroke

Olegi N Kukaliia¹, Sergei V Ageev², Andrey V Petrov³, Olga V Kirik⁴, Dmitrii E Korzhevskii⁴, Anatolii A Meshcheriakov¹, Anastasia A Jakovleva¹, Liudmila S Poliakova¹, Tatiana A Novikova¹, Maria E Kolpakova¹, Timur D Vlasov¹, Oleg E Molchanov⁵, Dmitriy N Maistrenko⁵, Igor V Murin³, Vladimir V Sharoyko⁶, Konstantin N Semenov⁷

Affiliations

¹ Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia.
² Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia; Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia.
³ Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia.
⁴ Institute of Experimental Medicine, 12 Akademika Pavlova Str., Saint Petersburg, 197022, Russia.
⁵ A. M. Granov Russian Research Centre for Radiology and Surgical Technologies, 70 Leningradskaia Str., Saint Petersburg, 197758, Russia.
⁶ Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia; Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia; A. M. Granov Russian Research Centre for Radiology and Surgical Technologies, 70 Leningradskaia Str., Saint Petersburg, 197758, Russia. Electronic address: sharoyko@gmail.com.
⁷ Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia; Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia; A. M. Granov Russian Research Centre for Radiology and Surgical Technologies, 70 Leningradskaia Str., Saint Petersburg, 197758, Russia. Electronic address: knsemenov@gmail.com.

PMID: 37507062
DOI: 10.1016/j.nano.2023.102698

C₆₀ adduct with L-arginine as a promising nanomaterial for treating cerebral ischemic stroke

Olegi N Kukaliia et al. Nanomedicine. 2023 Sep.

. 2023 Sep:53:102698.

doi: 10.1016/j.nano.2023.102698. Epub 2023 Jul 26.

Authors

Affiliations

¹ Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia.
² Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia; Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia.
³ Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia.
⁴ Institute of Experimental Medicine, 12 Akademika Pavlova Str., Saint Petersburg, 197022, Russia.
⁵ A. M. Granov Russian Research Centre for Radiology and Surgical Technologies, 70 Leningradskaia Str., Saint Petersburg, 197758, Russia.
⁶ Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia; Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia; A. M. Granov Russian Research Centre for Radiology and Surgical Technologies, 70 Leningradskaia Str., Saint Petersburg, 197758, Russia. Electronic address: sharoyko@gmail.com.
⁷ Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg, 197022, Russia; Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Pr., Saint Petersburg, 198504, Russia; A. M. Granov Russian Research Centre for Radiology and Surgical Technologies, 70 Leningradskaia Str., Saint Petersburg, 197758, Russia. Electronic address: knsemenov@gmail.com.

PMID: 37507062
DOI: 10.1016/j.nano.2023.102698

Abstract

The work aimed to investigate the biocompatibility and biological activity of the water-soluble fullerene adduct C₆₀-Arg. It was found that the material is haemocompatible, is not cyto- and genotoxic, possesses pronounced antioxidant activity. Additionally, this paper outlines the direction of application of water-soluble fullerene adducts in the creation of neuroprotectors. It has been suggested that a putative mechanism of the protective action of the C₆₀-Arg adduct is associated with its antioxidant properties, the ability to penetrate the blood-brain barrier, and release nitrogen monoxide as a result of the catabolism of L-arginine residues, which promote vascular relaxation. The action of the C₆₀-Arg adduct was compared with the action of such an antioxidant as Edaravone, which is approved in Japan for the treatment of ischemic and haemorrhagic strokes.

Keywords: Antioxidant activity; Fullerene adduct; Haemocompatibility; Histology; Ischemia.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest There are no conflicts to declare.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

C₆₀ adduct with L-arginine as a promising nanomaterial for treating cerebral ischemic stroke

Affiliations

C₆₀ adduct with L-arginine as a promising nanomaterial for treating cerebral ischemic stroke

Authors

Affiliations

Abstract

Conflict of interest statement

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical